Compare TWI & HQL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | TWI | HQL |
|---|---|---|
| Founded | 1890 | 1992 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Steel/Iron Ore | Investment Managers |
| Sector | Industrials | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 518.0M | 512.1M |
| IPO Year | 1993 | N/A |
| Metric | TWI | HQL |
|---|---|---|
| Price | $11.06 | $16.90 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $11.50 | N/A |
| AVG Volume (30 Days) | ★ 582.8K | 120.9K |
| Earning Date | 02-26-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 11.56% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.79 |
| Revenue | ★ $1,801,577,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $4.04 | N/A |
| P/E Ratio | ★ N/A | $17.08 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $5.93 | $11.34 |
| 52 Week High | $10.94 | $14.37 |
| Indicator | TWI | HQL |
|---|---|---|
| Relative Strength Index (RSI) | 72.66 | 44.27 |
| Support Level | $8.55 | $16.61 |
| Resistance Level | $10.94 | $17.45 |
| Average True Range (ATR) | 0.41 | 0.32 |
| MACD | 0.16 | -0.03 |
| Stochastic Oscillator | 89.12 | 32.17 |
Titan International Inc is a manufacturer of wheels, tires, wheel and tire assemblies, and undercarriage systems and components for off-highway vehicles. The company operates through three segments namely Agricultural, Earthmoving/Construction, and Consumer. Geographically, business of the group can be seen in the United States, Europe / CIS, Latin America and Other international. Titan derives majority of the revenue from Agricultural segment which manufacture various agricultural equipment, including tractors, combines, plows, planters and irrigation equipment, and are sold directly to original equipment manufacturers and to the aftermarket through independent distributors, equipment dealers and Titan's own distribution centers.
abrdn Life Sciences Investors operates as a non-diversified closed-end management investment company. Its investment objective is to seek long-term capital appreciation by investing mainly in securities of life sciences companies. It invests in securities of public and private companies that are believed by the Fund's Investment Adviser to have the potential for above-average growth.